JP2004507519A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004507519A5 JP2004507519A5 JP2002523438A JP2002523438A JP2004507519A5 JP 2004507519 A5 JP2004507519 A5 JP 2004507519A5 JP 2002523438 A JP2002523438 A JP 2002523438A JP 2002523438 A JP2002523438 A JP 2002523438A JP 2004507519 A5 JP2004507519 A5 JP 2004507519A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- formula
- atom
- halogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 27
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 9
- -1 2,6-difluorobenzoyl Chemical group 0.000 claims 8
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 6
- 229910052731 fluorine Inorganic materials 0.000 claims 6
- 125000001153 fluoro group Chemical group F* 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 6
- 229910052801 chlorine Inorganic materials 0.000 claims 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 238000006243 chemical reaction Methods 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 229960005190 phenylalanine Drugs 0.000 claims 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 230000005494 condensation Effects 0.000 claims 2
- 238000009833 condensation Methods 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 230000002829 reductive effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22912800P | 2000-08-31 | 2000-08-31 | |
| PCT/US2001/026594 WO2002018320A2 (en) | 2000-08-31 | 2001-08-27 | INHIBITORS OF α4 MEDIATED CELL ADHESION |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004507519A JP2004507519A (ja) | 2004-03-11 |
| JP2004507519A5 true JP2004507519A5 (enExample) | 2005-02-24 |
| JP3899022B2 JP3899022B2 (ja) | 2007-03-28 |
Family
ID=22859926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002523438A Expired - Fee Related JP3899022B2 (ja) | 2000-08-31 | 2001-08-27 | α４介在細胞接着阻害剤 |
Country Status (28)
| Country | Link |
|---|---|
| US (6) | US7026501B2 (enExample) |
| EP (1) | EP1315694B1 (enExample) |
| JP (1) | JP3899022B2 (enExample) |
| KR (1) | KR100528049B1 (enExample) |
| CN (1) | CN1229334C (enExample) |
| AR (1) | AR034556A1 (enExample) |
| AT (1) | ATE292615T1 (enExample) |
| AU (2) | AU2001286778B2 (enExample) |
| BR (1) | BR0113629A (enExample) |
| CA (1) | CA2418054C (enExample) |
| CZ (1) | CZ303460B6 (enExample) |
| DE (1) | DE60109943T2 (enExample) |
| DK (1) | DK1315694T3 (enExample) |
| ES (1) | ES2240509T3 (enExample) |
| HK (1) | HK1052684B (enExample) |
| HU (1) | HUP0302693A3 (enExample) |
| IL (2) | IL154305A0 (enExample) |
| MX (1) | MXPA03001837A (enExample) |
| MY (1) | MY129000A (enExample) |
| NO (1) | NO327861B1 (enExample) |
| NZ (1) | NZ524043A (enExample) |
| PL (1) | PL206656B1 (enExample) |
| PT (1) | PT1315694E (enExample) |
| RU (1) | RU2250895C2 (enExample) |
| SI (1) | SI1315694T1 (enExample) |
| TW (1) | TWI224587B (enExample) |
| WO (1) | WO2002018320A2 (enExample) |
| ZA (1) | ZA200301039B (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK287781B6 (sk) | 2000-08-18 | 2011-09-05 | Ajinomoto Co., Inc. | Fenylalanínové deriváty, farmaceutický prípravok s ich obsahom a ich použitie |
| TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
| KR100881647B1 (ko) | 2001-04-27 | 2009-02-04 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 피라졸로[1,5-ａ]피리딘 화합물 및 그 의약 |
| MY140707A (en) * | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
| AU2003265398A1 (en) | 2002-08-09 | 2004-02-25 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds and methods to modulate coagulation |
| AU2003275589B2 (en) | 2002-10-22 | 2009-05-28 | Eisai R & D Management Co., Ltd. | 7-phenyl pyrazolopyridine compounds |
| US7176216B2 (en) | 2002-10-22 | 2007-02-13 | Eisai Co., Ltd. | 7-phenylpyrazolopyridine compounds |
| AU2004263508A1 (en) * | 2003-08-08 | 2005-02-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
| US7208601B2 (en) | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
| US7459472B2 (en) | 2003-08-08 | 2008-12-02 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
| EP2615087A3 (en) | 2003-12-22 | 2013-08-07 | Ajinomoto Co., Inc. | Phenylalanine derivatives |
| US7410971B2 (en) | 2003-12-26 | 2008-08-12 | Eisai R&D Management Co., Ltd. | 1,2-di(cyclic)substituted benzene compounds |
| MY140489A (en) | 2003-12-26 | 2009-12-31 | Eisai R&D Man Co Ltd | 1,2-di (cyclic) substituted benzene compounds |
| US7419666B1 (en) | 2004-02-23 | 2008-09-02 | Massachusetts Eye And Ear Infirmary | Treatment of ocular disorders |
| JP4966017B2 (ja) | 2004-12-20 | 2012-07-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | １−シクロプロピルメチル−４−［２−（３，３，５，５−テトラメチルシクロヘキシル）フェニル］ピペラジンの塩および結晶 |
| MX2007014721A (es) | 2005-06-09 | 2008-02-14 | Ucb Pharma Sa | Derivados de 2,6-quinolinilo, procesos para prepararlos y sus usos como medicamento. |
| WO2007060408A2 (en) * | 2005-11-23 | 2007-05-31 | Astrazeneca Ab | L-phenylalanine derivatives and their use as integrin antagonists |
| US7855291B2 (en) | 2005-12-29 | 2010-12-21 | Lexicon Pharmaceuticals, Inc. | Process for the preparation of substituted phenylalanines |
| US7723345B2 (en) * | 2005-12-29 | 2010-05-25 | Lexicon Pharmaceuticals, Inc. | Multicyclic amino acid derivatives and methods of their use |
| US7897763B2 (en) | 2005-12-29 | 2011-03-01 | Lexicon Pharmaceuticals, Inc. | Process for the preparation of substituted phenylalanines |
| IL172896A0 (en) * | 2005-12-29 | 2006-06-11 | Yeda Res & Dev | Cxcr4 inhibition |
| WO2007092471A2 (en) * | 2006-02-03 | 2007-08-16 | The Regents Of The University Of California | Methods for inhibition of lymphangiogenesis and tumor metastasis |
| US20090203663A1 (en) * | 2006-02-09 | 2009-08-13 | Astrazeneca Ab | Chemical compounds |
| WO2007100770A2 (en) * | 2006-02-28 | 2007-09-07 | Elan Pharmaceuticals, Inc. | Methods of treating inflammatory and autoimmune diseases with natalizumab |
| EP2007392A4 (en) * | 2006-02-28 | 2010-04-07 | Elan Pharm Inc | METHOD FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES WITH ALPHA-4-INHIBITABLE COMPOUNDS |
| MX2008011176A (es) | 2006-03-03 | 2008-09-10 | Elan Pharm Inc | Metodos para tratar padecimientos inflamatorios y autoinmunes con natalizumab. |
| US20090062540A1 (en) | 2007-08-24 | 2009-03-05 | Bednarz Mark S | Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds |
| KR101601994B1 (ko) | 2008-04-15 | 2016-03-17 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 3-페닐피라졸로[5,1-ｂ]티아졸 화합물 |
| AR078521A1 (es) | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
| JP2013508333A (ja) | 2009-10-21 | 2013-03-07 | グラクソ グループ リミテッド | フェニルアラニン誘導体を調製するためのプロセス |
| US11287423B2 (en) | 2010-01-11 | 2022-03-29 | Biogen Ma Inc. | Assay for JC virus antibodies |
| LT4152004T (lt) | 2010-01-11 | 2025-02-25 | Biogen Ma Inc. | Tyrimas, skirtas antikūnams prieš jc virusą nustatyti |
| EP4187248A1 (en) | 2011-05-31 | 2023-05-31 | Biogen MA Inc. | Method of assessing risk of pml |
| US20150010563A1 (en) * | 2012-02-21 | 2015-01-08 | Massachusetts Eye & Ear Infirmary | Methods for Treating Corneal and Conjunctival Inflammation and Inflammatory Disorders |
| HK1216546A1 (zh) | 2013-05-28 | 2016-11-18 | Biogen Ma Inc. | 评估pml风险的方法 |
| WO2018085552A1 (en) * | 2016-11-02 | 2018-05-11 | Saint Louis University | Integrin antagonists |
| ES3013256T3 (en) | 2018-10-30 | 2025-04-11 | Gilead Sciences Inc | Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases |
| HUE070112T2 (hu) | 2018-10-30 | 2025-05-28 | Gilead Sciences Inc | 3-(Kinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidin-2,4-dion-származékok mint alpha4beta7 integrin gátlók gyulladásos betegségek kezelésére |
| CA3115830C (en) | 2018-10-30 | 2023-09-12 | Gilead Sciences, Inc. | Compounds for inhibition of .alpha.4.beta.7 integrin |
| KR102652797B1 (ko) | 2018-10-30 | 2024-04-02 | 길리애드 사이언시즈, 인코포레이티드 | 알파4베타7 인테그린의 억제를 위한 화합물 |
| WO2021030438A1 (en) | 2019-08-14 | 2021-02-18 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK148576A (da) | 1975-04-18 | 1976-10-19 | Boehringer Mannheim Gmbh | Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling |
| WO1995012611A1 (en) | 1993-11-01 | 1995-05-11 | Japat Ltd. | Endothelin receptor antagonists |
| MX9604368A (es) | 1994-03-28 | 1997-12-31 | Ciba Geigy Japan Ltd | Antagonistas de receptores de endotelina. |
| US6306840B1 (en) | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| WO1996033170A1 (en) | 1995-04-21 | 1996-10-24 | Novarits Ag | N-aroylamino acid amides as endothelin inhibitors |
| ES2257808T3 (es) | 1997-05-29 | 2006-08-01 | MERCK & CO., INC. (A NEW JERSEY CORP.) | Acidos biarilalcanoicos como inhibidores de adhesion celular. |
| WO1998053818A1 (en) | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Sulfonamides as cell adhesion inhibitors |
| WO1998053814A1 (en) | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| ATE256699T1 (de) | 1997-05-30 | 2004-01-15 | Celltech Therapeutics Ltd | Entzündungshemmende tyrosin-derivate |
| PT991619E (pt) | 1997-06-23 | 2004-02-27 | Upjohn Co | Inibidores da adesao celular mediada pela alfa4beta1 |
| BR9812111A (pt) | 1997-07-31 | 2000-07-18 | Elan Pharm Inc | Dipeptìdeo e compostos correlatos que inibem adesão de leucócito mediada por vla-4 |
| EP1001973A1 (en) | 1997-07-31 | 2000-05-24 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| IL133635A0 (en) | 1997-07-31 | 2001-04-30 | Elan Pharm Inc | Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| EP0994896A1 (en) | 1997-07-31 | 2000-04-26 | Elan Pharmaceuticals, Inc. | Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| AR016133A1 (es) | 1997-07-31 | 2001-06-20 | Wyeth Corp | Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria |
| CN1265673A (zh) | 1997-07-31 | 2000-09-06 | 伊兰药品公司 | 抑制由vla－4介导的白细胞粘着的二肽化合物 |
| IL133638A0 (en) | 1997-07-31 | 2001-04-30 | Elan Pharm Inc | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| CA2290747A1 (en) | 1997-07-31 | 1999-02-11 | Elan Pharmaceuticals, Inc. | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| KR100615760B1 (ko) | 1997-08-22 | 2006-08-25 | 에프. 호프만-라 로슈 아게 | 엔-알카노일페닐알라닌 유도체 |
| AU739511B2 (en) | 1997-08-22 | 2001-10-11 | F. Hoffmann-La Roche Ag | N-aroylphenylalanine derivatives |
| US6191171B1 (en) | 1997-11-20 | 2001-02-20 | Merck & Co., Inc. | Para-aminomethylaryl carboxamide derivatives |
| AU1463499A (en) | 1997-11-21 | 1999-06-15 | Merck & Co., Inc. | Substituted pyrrole derivatives as cell adhesion inhibitors |
| JP2001524465A (ja) | 1997-11-24 | 2001-12-04 | メルク エンド カムパニー インコーポレーテッド | 細胞接着阻害剤としての置換β−アラニン誘導体 |
| WO1999026615A1 (en) | 1997-11-24 | 1999-06-03 | Merck & Co., Inc. | Cyclic amino acid derivatives as cell adhesion inhibitors |
| US6197794B1 (en) | 1998-01-08 | 2001-03-06 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| MY153569A (en) * | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
| US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| DE69919334T2 (de) | 1998-02-26 | 2005-08-04 | Celltech Therapeutics Ltd., Slough | Phenylalaninderivate als inhibitoren von alpha4 integrinen |
| US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
| GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9812088D0 (en) | 1998-06-05 | 1998-08-05 | Celltech Therapeutics Ltd | Chemical compounds |
| AU8059598A (en) | 1998-06-11 | 1999-12-30 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| TW591026B (en) | 1998-06-23 | 2004-06-11 | Upjohn Co | Inhibitors of alpha4beta1 mediated cell adhesion |
| ES2220140T3 (es) | 1998-12-22 | 2004-12-01 | Tanabe Seiyaku Co., Ltd. | Inhibidores de la adhesion mediada de celulas por alfa 4 beta 1 (a4b1). |
| GB2354440A (en) | 1999-07-20 | 2001-03-28 | Merck & Co Inc | Aryl amides as cell adhesion inhibitors |
| WO2001012183A1 (en) | 1999-08-16 | 2001-02-22 | Merck & Co., Inc. | Heterocycle amides as cell adhesion inhibitors |
| WO2001014328A2 (en) | 1999-08-20 | 2001-03-01 | Merck & Co., Inc. | Substituted ureas as cell adhesion inhibitors |
| DE60035204T2 (de) | 1999-09-24 | 2008-02-21 | Genentech, Inc., South San Francisco | Tyrosinderivate |
| AU2001284649A1 (en) | 2000-08-31 | 2002-03-13 | Eli Lilly And Company | Acetylenic sulfonamide derivatives |
-
2001
- 2001-08-21 MY MYPI20013917A patent/MY129000A/en unknown
- 2001-08-27 DE DE60109943T patent/DE60109943T2/de not_active Expired - Lifetime
- 2001-08-27 AT AT01966246T patent/ATE292615T1/de active
- 2001-08-27 AU AU2001286778A patent/AU2001286778B2/en not_active Ceased
- 2001-08-27 WO PCT/US2001/026594 patent/WO2002018320A2/en not_active Ceased
- 2001-08-27 PT PT01966246T patent/PT1315694E/pt unknown
- 2001-08-27 ES ES01966246T patent/ES2240509T3/es not_active Expired - Lifetime
- 2001-08-27 CA CA 2418054 patent/CA2418054C/en not_active Expired - Fee Related
- 2001-08-27 HK HK03105043.3A patent/HK1052684B/en not_active IP Right Cessation
- 2001-08-27 IL IL15430501A patent/IL154305A0/xx unknown
- 2001-08-27 AU AU8677801A patent/AU8677801A/xx active Pending
- 2001-08-27 RU RU2003105885/04A patent/RU2250895C2/ru not_active IP Right Cessation
- 2001-08-27 SI SI200130351T patent/SI1315694T1/xx unknown
- 2001-08-27 KR KR10-2003-7001993A patent/KR100528049B1/ko not_active Expired - Fee Related
- 2001-08-27 DK DK01966246T patent/DK1315694T3/da active
- 2001-08-27 JP JP2002523438A patent/JP3899022B2/ja not_active Expired - Fee Related
- 2001-08-27 NZ NZ524043A patent/NZ524043A/en not_active IP Right Cessation
- 2001-08-27 ZA ZA200301039A patent/ZA200301039B/xx unknown
- 2001-08-27 BR BR0113629-1A patent/BR0113629A/pt active Search and Examination
- 2001-08-27 HU HU0302693A patent/HUP0302693A3/hu unknown
- 2001-08-27 MX MXPA03001837A patent/MXPA03001837A/es active IP Right Grant
- 2001-08-27 CN CNB018149871A patent/CN1229334C/zh not_active Expired - Fee Related
- 2001-08-27 US US10/333,985 patent/US7026501B2/en not_active Expired - Fee Related
- 2001-08-27 EP EP01966246A patent/EP1315694B1/en not_active Expired - Lifetime
- 2001-08-27 PL PL365668A patent/PL206656B1/pl unknown
- 2001-08-27 CZ CZ20030487A patent/CZ303460B6/cs not_active IP Right Cessation
- 2001-08-31 TW TW090121581A patent/TWI224587B/zh not_active IP Right Cessation
- 2001-08-31 AR ARP010104172A patent/AR034556A1/es active IP Right Grant
-
2003
- 2003-02-05 IL IL154305A patent/IL154305A/en not_active IP Right Cessation
- 2003-02-25 NO NO20030885A patent/NO327861B1/no not_active IP Right Cessation
-
2005
- 2005-07-13 US US11/179,729 patent/US7456217B2/en not_active Expired - Fee Related
-
2008
- 2008-10-07 US US12/247,129 patent/US7671090B2/en not_active Expired - Fee Related
-
2010
- 2010-01-07 US US12/683,648 patent/US7872151B2/en not_active Expired - Fee Related
- 2010-12-08 US US12/962,707 patent/US8501809B2/en not_active Expired - Fee Related
-
2013
- 2013-07-03 US US13/934,405 patent/US20130289109A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004507519A5 (enExample) | ||
| JP2009533369A5 (enExample) | ||
| JP2005526011A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| JP2001261662A5 (enExample) | ||
| JP2005517666A5 (enExample) | ||
| JP2005533789A5 (enExample) | ||
| JP2007510619A5 (enExample) | ||
| JP2007501809A5 (enExample) | ||
| JP2004535412A5 (enExample) | ||
| JPH10279578A5 (enExample) | ||
| JP2005511697A5 (enExample) | ||
| JP2004531479A5 (enExample) | ||
| JPH1077292A5 (enExample) | ||
| RU2004128935A (ru) | Способ получения производных фенилаланина и их полупродуктов | |
| RU2010131010A (ru) | Способ получения 6-замещенных-1-(2н)-изохинолинонов | |
| JP2004506769A5 (enExample) | ||
| JP2005502603A5 (enExample) | ||
| JP2003012683A5 (enExample) | ||
| JP2002519409A5 (enExample) | ||
| JP2002121189A5 (enExample) | ||
| JP2004018389A5 (enExample) | ||
| JP2005513126A5 (enExample) | ||
| JP2003105259A5 (enExample) | ||
| JP2005531529A5 (enExample) |